Where Pharma Leaders Come to See the Full Picture

Unlike pharma-specific conferences, HLTH USA is where scientists, commercial leaders, and R&D executives engage directly with the health systems, payers, employers, and investors who determine adoption and access. It’s where partnerships get sourced, collaborations get built, and the hard conversations about what’s working and what isn’t actually happen.

Why Pharma Leaders Attend

To engage the ecosystem that determines whether their innovations reach patients

HLTH USA puts pharma leaders in direct conversation with health system CMOs, payer executives, and employer benefits leaders, the people who ultimately control formulary decisions, coverage policies, and clinical adoption. These are conversations that don't happen at pharma-only events.

To find partners across digital health, AI, and clinical trial innovation

Market Connect provides pre-vetted 1:1 meetings with solution providers across AI drug discovery, real-world data platforms, digital therapeutics, and clinical trial technology matched to specific R&D, commercial, and BD priorities. Qualify and your pass could be complimentary. 

Because the agenda addresses the forces reshaping the industry

From GLP-1 economics and Medicare drug price negotiation to AI-driven drug discovery and direct-to-patient models, the HLTH USA agenda tackles the cross-sector dynamics pharma leaders can't get full visibility on from within their own industry events.

To benchmark strategy against peers and the broader market

Biotech founders, global pharma executives, CRO leaders, and AI drug development companies are all at HLTH USA, alongside the policymakers writing the rules and the investors backing the next wave of innovation.

Who You Can Expect Onsite

AbbVie
Amgen
Astellas
AstraZeneca
Bayer
Biogen
Boehringer Ingelheim
Bristol Myers Squibb
Eisai
Eli Lilly
Genentech
Gilead
GSK
Johnson & Johnson
Merck
Novartis

Past Sessions

Longevity Wonder Drugs

GLP-1 medications started as diabetes drugs, graduated to weight loss superstars, and are now showing evidence of benefits across cardiovascular disease, kidney function, addiction recovery, and neurological conditions. This Power Panel explored the full scope of their therapeutic potential, the infrastructure needed to support long-term adherence, and what it means for pharma's commercial strategy. Moderated by The Washington Post, with speakers from WeightWatchers, Humanaut Health, and Barzilai Longevity Consulting. Watch Now

The Hinge Moment: Artificial Intelligence, Human Data, and Drug Development in the 21st Century

AI is transforming how we understand and treat disease, not just by speeding up development, but by unlocking deeper insights into human biology through massive, diverse datasets. This session explored how life sciences companies are using AI, molecular engineering, and real-world data to advance precision medicine from identifying the right treatments for the right patients to designing personalized therapeutic approaches. Speakers from Amgen and the Cancer Research Institute, moderated by University of California Health. Watch Now

Oh, the Places TechBio Will Go

Traditional biotech companies are joining forces with AI-first startups, creating hybrid entities that can crunch genomic data while navigating the messy realities of drug development that have humbled many a tech entrepreneur. This session examined how the TechBio category — spanning computational drug discovery, synthetic biology, and AI-powered diagnostics — is producing AI-designed drugs entering clinical trials and attracting venture capital at unprecedented valuations. The conversation also addressed the fundamental tension TechBio companies face: you can't debug your way out of biology. Speakers from Generate Biomedicines and Recursion Pharmaceuticals, with Menlo Ventures. Watch Now

VIEW MORE SESSIONS

Our Sponsors

Loading...

Hear From Past Attendees

"If you're coming to HLTH, make sure to join Market Connect. It is surefire one of the greatest ways to make those deep connections and partnerships as you work with your organization to solve the next set of challenges and really drive innovation."
Director, Enterprise Innovation AbbVie
"A lot of the recent AI themes have been incorporated into the program, which is obviously very relevant to what my company is looking for."
Executive Director of IT ProcurementBristol Myers Squibb

Your Next Step

Learn more HLTH USA and be at the forefront of payer innovation. Empower yourself with the knowledge and connections to transform operations and reimbursement within your institution.

REGISTER & JOIN US
BECOME A SPONSOR

Filter Sessions